Racho Strauven
Racho Strauven is the EMEA vice president for health economics & market access at Boston Scientific, which is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.
HSJ PartnersHarnessing innovation to transform Afib treatment
Boston Scientific’s Racho Strauven explains how pulsed field ablation (PFA) is a cost-saving alternative for treating atrial fibrillation (AF). He highlights a study published in BMJ Open that suggests PFA could save the NHS an average of £343 per patient, paving the way for improved patient outcomes and healthcare efficiency.